Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by Noteableon Dec 14, 2022 10:46am
197 Views
Post# 35170795

Another sad memorial / remembrance

Another sad memorial / remembrance

 

A mum who was diagnosed with breast cancer on the day she gave birth to her daughter has passed away from the disease. 

Despite defying the odds and living for 19 months compared to the short time doctors initially gave her, Karyn Love, from Brisbane, lost her battle with cancer this week.

Her family announced the loss on Instagram alongside a tribute to her, with a “life celebration ceremony” to be held in remembrance.

“Karyn Louise Love. 1983 - 2022. Smile for me, I am free,” the post read.

---------------------------------------------

 

Ms Love had announced that she was “gravely unwell” more than a year ago while pregnant with baby Billi, with fears she could lose her child due to the disease.

She was rushed to the hospital at 29 weeks with severe backpain.

“She was told she needed an emergency caesarian immediately otherwise she and her baby may not make it,” a friend wrote on a GoFundMe campaign.

“An hour after Billi was born Karyn was diagnosed with Stage 4 Breast Cancer that had spread to her liver, bones and optic nerve.”

<< Previous
Bullboard Posts
Next >>